Drug for preventing or treating angiogenic eye diseases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4178 (2006.01) A61K 45/00 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2522318

A medicament for the prevention or treatment of intraocular angiogenic diseases such as proliferative retinopathy, retinal vein occlusion, retinal artery occlusion or age-related macular degeneration, which comprises an angiotensin II receptor antagonist such as 4- (1-hydroxy-1-methylethyl)-2-propyl-1-[2'-(1H-tetrazol-5- yl)biphenyl-4-ylmethyl]imidazole-5-carboxylic acid as its active ingredient.

La présente invention concerne un médicament destiné à la prévention ou au traitement de maladies oculaires angiogéniques telles que la rétinopathie proliférative, l'obstruction des veines rétiniennes, l'obstruction des artères rétiniennes ou la dégénérescence maculaire liée à l'âge, lequel médicament contient comme principe actif un antagoniste du récepteur II de l'angiotensine tel qu'un acide 4-(1-hydroxy-1-méthyléthyl)-2-propyl-1-[2'-(1H-tétrazol-5-yl)biphényl-4-ylméthyl]imidazole-5-carboxylique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Drug for preventing or treating angiogenic eye diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug for preventing or treating angiogenic eye diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug for preventing or treating angiogenic eye diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1768278

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.